Angela A.G. van Tilborg

Author

Also Known As

A A G Van Tilborg, A A G van Tilborg, A. A. G. Van Tilborg, A. A. G. van Tilborg, A. A.G. van Tilborg, A.A.G van Tilborg, A.A.G. VAN TILBORG, A.A.G. Van Tilborg, ANGELA A.G. VAN TILBORG, Angela A G van Tilborg

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam Erasmus MC Radboud University Nijmegen Radboud University Medical Center University of Amsterdam

About

Angela A.G. van Tilborg is an author at Erasmus University Rotterdam specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.5K
2	Cell Biology	4	4	545
3	Engineering	3	3	289
4	Health Sciences	1	1	18
5	Immunology	1	1	46

Angela A.G. van Tilborg

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma Shahryar E. Mir, Philip C. De Witt Hamer, Przemek M. Krawczyk, Cancer Cell Neuro-oncologySilico AnalysisGliomaMedicineReceptor Tyrosine Kinase	2010	290
Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome Yves Allory, Willemien Beukers, Ana Sagrera, European Urology UrologySomatic VariantGenitourinary CancerMedicinePathology	2013	280
The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids Philip C. De Witt Hamer, Angela A.G. van Tilborg, Paul P. Eijk, Oncogene Developmental BiologyHuman Malignant GliomaTumor HeterogeneityMedicinePrimary Cell Culture	2007	218
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders Bas W.G. van Rhijn, Angela A.G. van Tilborg, Irene Lurkin, European Journal of Human Genetics Tumor BiologyUrologyGenitourinary CancerPathologyFibroblast Growth Factor	2002	148
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers Raju Kandimalla, Angela A.G. van Tilborg, Lucie C. Kompier, European Urology UrologyEngineeringMedicineEpigenomicsCancer Genomics	2012	105
Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes Irene Lurkin, Robert Stoehr, Carolyn D. Hurst, PLoS ONE EngineeringGeneticsPik3ca GenesPathologyGene Characterization	2010	94
Molecular evolution of multiple recurrent cancers of the bladder Angela A.G. van Tilborg Human Molecular Genetics UrologyEngineeringSomatic VariantGenitourinary CancerTumor Heterogeneity	2000	90
A 3-Plex Methylation Assay Combined with the <i>FGFR3</i> Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine Raju Kandimalla, Roy Masius, Willemien Beukers, Clinical Cancer Research	2013	59
Expression of Granzymes A and B in Synovial Tissue from Patients with Rheumatoid Arthritis and Osteoarthritis J. Alain Kummer, Paul P. Tak, Brigitta M. N. Brinkman, Clinical Immunology and Immunopathology InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseGranulocyte	1994	46
Prognostic significance of highly sulfated chondroitin sulfates in ovarian cancer defined by the single chain antibody GD3A11 Sophieke C.H.A. van der Steen, Angela A.G. van Tilborg, Myrtille J.E. Vallen, Gynecologic Oncology Chondroitin SulfatesTumoral PathologyMedicineGynecologyPathology	2015	37

Page 1